Indeed, international collaboration in this space is essential for the advancement of the work. A concrete example that is pertinent here would be the development of the Ebola monoclonal antibody cocktail involved in the development of multiple components of that treatment, some of which came from American innovation and advancement. It is by putting together those advances that the ultimate product was realized.
By extension, our ability to collaborate internationally and to bring together the best minds to tackle the problems at hand are an essential feature of that work. However, we are very cognizant, and have become even more so, of the shifting threat environment that we operate in. Hence, any new collaborations that are borne out at the NML involve a security dimension and security review prior to our commencing the work.